YU14602A - Signalna sekvenca za proizvodnju leu-hirudina pomoću sekrecija e.coli u medijumu kulture - Google Patents

Signalna sekvenca za proizvodnju leu-hirudina pomoću sekrecija e.coli u medijumu kulture

Info

Publication number
YU14602A
YU14602A YU14602A YUP14602A YU14602A YU 14602 A YU14602 A YU 14602A YU 14602 A YU14602 A YU 14602A YU P14602 A YUP14602 A YU P14602A YU 14602 A YU14602 A YU 14602A
Authority
YU
Yugoslavia
Prior art keywords
hirudine
coli
leu
production
signal sequences
Prior art date
Application number
YU14602A
Other languages
English (en)
Inventor
Paul Habermann
Rudolf Bender
Original Assignee
Aventis Pharma Deutschland Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh. filed Critical Aventis Pharma Deutschland Gmbh.
Publication of YU14602A publication Critical patent/YU14602A/sh
Publication of RS50435B publication Critical patent/RS50435B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • C12N15/625DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Abstract

Ovaj pronalazak se odnosi na hirudinski prekursor koji sadrži signalnu sekvenciju i sekvenciju leu-hirudina, njegovu proizvodnju i primenu, kao i na postupak za detekciju signalnih sekvencija za sekretsku ekspresiju bilo kojih proteina u E.coli i postupak za sekretsku ekspresiju bilo kojeg proteina u E.coli.[The invention relates to a hirudine precursor containing a signal sequence and production of said leu-hirudine, utilization of said sequence and a method for detecting said signal sequences for secretarial expression of any given protein E. coli and a method for secretarial expression of any given protein E. coli.
YUP-146/02A 1999-09-18 2000-09-01 Signalne sekvence za proizvodnju leu-hirudina pomoću sekrecija e.coli u medijumu kulture RS50435B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19944870A DE19944870A1 (de) 1999-09-18 1999-09-18 Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium

Publications (2)

Publication Number Publication Date
YU14602A true YU14602A (sh) 2005-07-19
RS50435B RS50435B (sr) 2009-12-31

Family

ID=7922547

Country Status (29)

Country Link
US (1) US7455987B1 (sh)
EP (1) EP1216259B1 (sh)
JP (1) JP4669181B2 (sh)
KR (1) KR100737189B1 (sh)
CN (2) CN1192037C (sh)
AR (1) AR025660A1 (sh)
AT (1) ATE357458T1 (sh)
AU (1) AU775923B2 (sh)
BR (1) BR0014519A (sh)
CA (1) CA2385287C (sh)
CZ (1) CZ2002899A3 (sh)
DE (2) DE19944870A1 (sh)
DK (1) DK1216259T3 (sh)
EE (1) EE05187B1 (sh)
HK (2) HK1049172A1 (sh)
HR (1) HRP20020226B1 (sh)
HU (1) HUP0202596A3 (sh)
IL (2) IL148624A0 (sh)
ME (1) MEP27908A (sh)
MX (1) MXPA02002469A (sh)
NO (1) NO329723B1 (sh)
NZ (1) NZ517825A (sh)
PL (1) PL205117B1 (sh)
RS (1) RS50435B (sh)
RU (1) RU2261867C2 (sh)
SK (1) SK287865B6 (sh)
TR (2) TR200501541T2 (sh)
WO (1) WO2001021662A1 (sh)
ZA (1) ZA200202106B (sh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
EP2327718B1 (en) 2003-11-21 2016-03-23 Pfenex, Inc. Improved expression systems with SEC-system secretion
CA2574953A1 (en) 2004-07-26 2006-02-09 Dow Global Technolgies Inc. Process for improved protein expression by strain engineering
DE102005046113A1 (de) * 2005-09-27 2007-03-29 Sanofi-Aventis Deutschland Gmbh Verfahren zur Amidierung von Polypetiden mit C-terminalen basischen Aminosäuren unter Verwendung spezifischer Endoproteasen
DE102006044841A1 (de) * 2006-09-22 2008-04-03 Wacker Chemie Ag Signalpeptid zur Produktion von rekombinanten Proteinen
US7618799B2 (en) 2007-01-31 2009-11-17 Dow Global Technologies Inc Bacterial leader sequences for increased expression
CN101688213A (zh) 2007-04-27 2010-03-31 陶氏环球技术公司 用于快速筛选微生物宿主以鉴定某些在表达异源蛋白质方面具有改善的产量和/或质量的菌株的方法
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
AU2014248768A1 (en) 2013-03-12 2015-09-24 Massachusetts Eye And Ear Infirmary Modified mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases
ES2912283T3 (es) 2013-12-11 2022-05-25 Massachusetts Gen Hospital Uso de proteínas de tipo sustancia inhibidora mülleriana (SIM) para la anticoncepción y conservación de la reserva ovárica
CN108220369B (zh) * 2017-12-04 2021-03-12 广东双骏生物科技有限公司 一种生产重组水蛭素的方法
CN108359689B (zh) * 2018-01-19 2021-03-23 华中农业大学 利用抗病基因识别无毒效应蛋白以鉴定具有分泌功能信号肽的方法
CN115572329B (zh) * 2021-06-21 2024-02-06 王大勇 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
FI96956C (fi) * 1985-04-11 1996-09-25 Hoechst Ag Menetelmä terapeuttisesti käyttökelpoisen hirudiinijohdannaisen valmistamiseksi
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
AU604925B2 (en) * 1988-02-23 1991-01-03 Schering Aktiengesellschaft A hirudin derivative
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
DK0511393T3 (da) * 1990-11-08 1996-12-09 Japan Energy Corp Hirudin-mutant, fremstilling af denne, antikoagulant, sekretorisk vektor, mikroorganisme transformeret af vektoren og fremstilling af produkt ud fra mikroorganismen
JPH07119237B2 (ja) * 1990-11-08 1995-12-20 株式会社ジャパンエナジー ヒルジン変異体,その製造法及び抗凝血剤
NZ243084A (en) * 1991-06-12 1995-08-28 Regeneron Pharma Production and recovery of recombinant neurotrophins, genes for a modified lamb signal sequence, fusion genes and plasmids
US5389529A (en) * 1991-06-12 1995-02-14 Regeneron Pharmaceuticals, Inc. Modified lamβ signal sequence and processes for producing recombinant neurotrophins
DE4140381A1 (de) 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet

Also Published As

Publication number Publication date
NO20021254D0 (no) 2002-03-13
PL354444A1 (en) 2004-01-12
CN1269838C (zh) 2006-08-16
IL148624A (en) 2009-08-03
HUP0202596A3 (en) 2005-01-28
CN1192037C (zh) 2005-03-09
AU775923B2 (en) 2004-08-19
ATE357458T1 (de) 2007-04-15
HRP20020226A2 (en) 2004-04-30
CN1550502A (zh) 2004-12-01
EE05187B1 (et) 2009-06-15
MXPA02002469A (es) 2002-08-28
TR200200667T2 (tr) 2002-06-21
EE200200139A (et) 2003-06-16
EP1216259B1 (de) 2007-03-21
JP4669181B2 (ja) 2011-04-13
AR025660A1 (es) 2002-12-11
RS50435B (sr) 2009-12-31
MEP27908A (en) 2010-10-10
NZ517825A (en) 2004-07-30
RU2261867C2 (ru) 2005-10-10
SK287865B6 (sk) 2012-02-03
US7455987B1 (en) 2008-11-25
WO2001021662A1 (de) 2001-03-29
ZA200202106B (en) 2003-01-09
HK1068352A1 (en) 2005-04-29
CN1374970A (zh) 2002-10-16
HK1049172A1 (en) 2003-05-02
PL205117B1 (pl) 2010-03-31
DE50014189D1 (de) 2007-05-03
DK1216259T3 (da) 2007-07-02
KR20020034188A (ko) 2002-05-08
HRP20020226B1 (en) 2010-08-31
DE19944870A1 (de) 2001-03-29
CA2385287A1 (en) 2001-03-29
CZ2002899A3 (cs) 2002-06-12
KR100737189B1 (ko) 2007-07-10
BR0014519A (pt) 2002-06-11
EP1216259A1 (de) 2002-06-26
IL148624A0 (en) 2002-09-12
NO20021254L (no) 2002-05-07
NO329723B1 (no) 2010-12-06
SK3622002A3 (en) 2003-06-03
AU6842100A (en) 2001-04-24
JP2003510041A (ja) 2003-03-18
RU2002110278A (ru) 2004-03-27
TR200501541T2 (tr) 2005-06-21
HUP0202596A2 (hu) 2002-12-28
CA2385287C (en) 2010-10-19

Similar Documents

Publication Publication Date Title
YU14602A (sh) Signalna sekvenca za proizvodnju leu-hirudina pomoću sekrecija e.coli u medijumu kulture
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
ES2145015T3 (es) Proteasas especificas de ubiquitina.
ATE293696T1 (de) Mutierte alpha-amylase enzyme mit erhöhter stabilität
MXPA04004874A (es) Procedimiento para producir l-aminoacido utilizando escherichia.
IL151960A0 (en) Production of polyketides
DK0981630T3 (da) Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme
FI951680A0 (fi) DNA-yhdisteitä, jotka sisältävät mannuronaani-C-5-epimeraasia koodaavia sekvenssejä
EP1553171A4 (en) NEW ENZYM-FORMING PEPTIDE, THIS PRODUCING MICRO-ORGANISM AND METHOD FOR PRODUCING DIPEPTIDE USING THE SAME
ZA200001354B (en) Process for the production of L-amino acids by fermentation using coryneform bacteria.
TR200200048T2 (tr) Otoproteolitik klevaj vasıtasıyla proteinlerin üretimi.
EP1250439A4 (en) EXPRESSION AND SECRETION VECTOR FOR THE HUMAN INTERPERON ALPHA AND PROCESS FOR OBTAINING THE HUMAN INTERFERON ALPHA USING THE SAME
DE69729010D1 (de) Produktion des proteins ingap mit hoher expressionsrate
HK1052029A1 (en) Method for increasing the yield of recombinant proteins in microbial fermentation processes.
AU8011498A (en) Novel ppgpp synthetase and expression systems for improved production of proteinof interest
ATE423205T1 (de) Verfahren zur biologischen herstellung von l- pipekolinsäure
DK1030867T3 (da) Vækstfaktor af mælk fra pattedyr
DE60026049D1 (de) POLYPEPTIDE MIT GLUCANOTRANSFERASE AKTIVITÄT UND DAFüR KODIERENDE NUKLEINSÄUREN
AU1703201A (en) Method for enhancing secretion of beta-lactam transport
ATE346920T1 (de) Neues immunoregulatorisches protein lst-1
ATE123524T1 (de) Herstellungsverfahren für chymosin.
WO2001019982A3 (en) Micro-organisms, their use and method for producing d-amino acids
UA40901A (uk) Спосіб визначення антимікробної активності бактисубтіла